HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 25, No. 09, September 2021 – The Rise of Alternative Proteins       » The Key to Improving Iron Content in Crops       » Breeding Non-GMO Plants With Next-Generation Chloroplast Gene-Editing       » New Lipomer Can Now Safely Deliver RNA Drugs to Lungs       » Preventing Deadly Post-Transplant Infection With Llama Nanobodies       » Insulin-Producing Implants: The Future of Care for Type 1 Diabetes      
Vol 23, No. 11, November 2019   |   Issue PDF view/purchase
EDITOR'S LETTER
The economics of genetic testing

Since the completion of the human genome project in April of 2003 a bevy of applications emerged from the detailed information of the entire structure and sequence of the human genome. One such application is genetic testing where information about someone’s DNA and chromosomes may possibly be linked to a disease manifestation later in life or diagnosis. A common use of genetic testing is for diagnostics. More specifically, cancer diagnostics, where a tissue sample is obtained by biopsy that may help to predict prognosis, risk of disease, and provide information for treatment plans.

With molecular diagnostic technologies such as next-generation sequencing, it has made cancer genetic diagnostic tests more available. However, this begs the question of the cost effectiveness of the process and its viability in enhancing cancer management. Our cover story for this month by experts from ACT genomics, Singapore will elucidate with insights from a health economics perspective on the cost effectiveness of genomic profiling technology in cancer management. (p. 30)

Another highlight of November is the International Day of Radiology held on the 8th of November. This event is held annually to raise awareness and express gratitude to the field of radiology and its contributions to the medical world in bringing better treatments and diagnosis. In line with that we sat down with Per Edlund, the Head of Commercial Operations at Bayer Radiology Asia Pacific to discuss this ever-evolving field on how Bayer has been committed to bringing better patient outcomes through radiology for over 100 years. (p. 14)

Shining bright in our spotlights section this month are the many events that took place through September and October 2019. One highlight was the One-North Festival 2019 held from the 13th to 14th of September 2019. (p. 38) Organized by A*STAR, JTC and Science Centre Singapore the annual event showcases innovations from science and technology in an interactive manner where the public can experience.

We bring you a range of articles covering healthcare and public health in our columns segment this month. Sharing with you about clinical research studies that will lead the way for better healthcare (p. 20), artificial intelligence applications in healthcare (p. 22), and how one research initiative is solving the global threat of antimicrobial resistance. (p. 18)


Deborah Emmanuel SEAH Qing En
Editor
You can reach me at qeseah@wspc.com

 

You can always access all APBN's issues on our website: www.asiabiotech.com.
Check us out at Facebook @Asia Pacific Biotech News, Instagram @asiabiotech, or follow us on Twitter @asia_biotech.

 

NEWS CRUNCH  
news TechInnovation 2021 Virtual Exhibition to Showcase Sustainable Energy, Food, and Healthcare Solutions
news A New Approach for Effective Gout Treatment
news TechInnovation Returns from 28 to 30 September 2021
news Singapore Health & Biomedical Congress 2021 is Set to Brave the New Frontiers as We Revolutionise and Transform Healthcare
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen Chan
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy